PubMed ID:
28337405
Public Release Type:
Journal
Publication Year: 2017
DOI:
https://doi.org/10.1007/s11901-017-0336-z
Authors:
Goossens Nicolas, Bian C. Billie, Hoshida Yujin
Request IDs:
20830
Studies:
The Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial
Current clinical practice guidelines recommend regular hepatocellular carcinoma (HCC) surveillance with biannual ultrasound with or without serum alpha-fetoprotein uniformly applied to all patients with cirrhosis. However, clinical implementation of this one-size-fits-all strategy has been challenging as evidenced by very low application rate below 20% due to various reasons, including suboptimal performance of the surveillance modalities.